Abstract
Most of the pharmacological effects of Cannabis species have been attributed to their cannabinoid constituents, primarily Δ9-tetrahydrocannabinol and cannabidiol. Efficient methods of extraction, purification, and characterization of these compounds are necessary to obtain both enriched preparations and isolated compounds for therapeutic applications. In this study, forensic samples of Cannabis sativa L., Cannabaceae, were subjected to extraction, using maceration in two different solvents, methanol, and diethyl ether. These extracts were subjected to thermal decarboxylation and purification by liquid–liquid fractionation. Δ9-Tetrahydrocannabinol and cannabidiol concentrations from various extracts were quantified by high-performance liquid chromatography with UV detection. Extract cytotoxicity was assayed in vitro using human erythrocytes, mouse embryonic fibroblasts (NIH3T3), and murine melanoma (B16F10) cells. The B16F10 cell death mechanism was also evaluated after treatment with extract samples. The results demonstrated promising effects of various cannabinoid extracts in a murine melanoma cancer line.
Graphical abstract
Similar content being viewed by others
References
Abrams DI, Guzman M (2014) Cannabis in cancer care. Clin Pharmacol Ther 97:575–586. https://doi.org/10.1002/cpt.108
Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, Tundidor I, Andradas C, García-Taboada E, Wade J, Smith S, Guzmán M, Pérez-Gómez E, Gordon M, Sánchez C (2018) Appraising the “entourage effect”: antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem Pharmacol 157:285–293. https://doi.org/10.1016/j.bcp.2018.06.025
Blázquez C, Carracedo A, Barrado L, Real PJ, Fernández-Luna JL, Velasco G, Malumbres M, Guzmán M (2006) Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 20:2633–2635. https://doi.org/10.1096/fj.06-6638fje
Carpi S, Fogli S, Polini B et al (2017) Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. Toxicol in Vitro 40:272–279. https://doi.org/10.1016/j.tiv.2017.01.018
Chandra S, Lata H, ElSohly MA (2017) Cannabis sativa L. - botany and biotechnology. Cannabis sativa L. - Bot Biotechnol. Springer, Cham, 474 https://doi.org/10.1007/978-3-319-54564-6
Citti C, Pacchetti B, Vandelli MA, Forni F, Cannazza G (2018) Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). J Pharm Biomed Anal 149:532–540. https://doi.org/10.1016/j.jpba.2017.11.044
Fett MS, Mariot RF, Avila E, Montagnani V, Podestà A, Breschi MC, Romanini A, Stecca B, Nieri P (2019) 13-loci STR multiplex system for Brazilian seized samples of marijuana: individualization and origin differentiation. Int J Legal Med 133:373–384. https://doi.org/10.1007/s00414-018-1940-3
Feuser PE, Arévalo JMC, Junior EL, Rossi GR, Trindade ES, Rocha MEM, Jacques AV, Ricci-Júnior E, Santos-Silva MC, Sayer C, Araújo PHH (2016) Increased cellular uptake of lauryl gallate loaded in superparamagnetic poly(methyl methacrylate) nanoparticles due to surface modification with folic acid. J Mater Sci Mater Med 27:185. https://doi.org/10.1007/s10856-016-5796-0
Gagne SJ, Stout JM, Liu E, Boubakir Z, Clark SM, Page JE (2012) Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides. Proc Natl Acad Sci U S A 109:12811–12816. https://doi.org/10.1073/pnas.1200330109
Gordon R (2013) Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs 29:160–169. https://doi.org/10.1016/j.soncn.2013.06.002
Guzmán M (2003) Cannabinoids: potential anticancer agents. Nat Rev Cancer 3:745–755. https://doi.org/10.1038/nrc1188
Hill AJ, Williams CM, Whalley BJ, Stephens GJ (2012) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 133:79–97. https://doi.org/10.1016/j.pharmthera.2011.09.002
Houston R, Birck M, Hughes-Stamm S, Gangitano D (2017) Developmental and internal validation of a novel 13 loci STR multiplex method for Cannabis sativa DNA profiling. Leg Med 26:33–40. https://doi.org/10.1016/j.legalmed.2017.03.001
King JW (2019) The relationship between cannabis/hemp use in foods and processing methodology. Curr Opin Food Sci 28:32–40. https://doi.org/10.1016/j.cofs.2019.04.007
Li X, Tian X, Zhang J, Zhao X, Chen X, Jiang Y, Wang D, Pan W (2011) In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel. Int J Nanomedicine 6:1167–1184. https://doi.org/10.2147/IJN.S21445
Narmani A, Kamali M, Amini B, Salimi A, Panahi Y (2018) Targeting delivery of oxaliplatin with smart PEG-modified PAMAM G4 to colorectal cell line: in vitro studies. Process Biochem 69:178–187. https://doi.org/10.1016/j.procbio.2018.01.014
Pain S (2015) A potted history. Nature 525:S10–S11. https://doi.org/10.1038/525S10a
Ramachandran R, Saraswathy M (2014) Up-regulation of nuclear related factor 2 (NRF2) and antioxidant responsive elements by metformin protects hepatocytes against the acetaminophen toxicity. Toxicol Res 3:350–358. https://doi.org/10.1039/c4tx00032c
Ribeiro LOP, Avila E, Mariot RF, Fett MS, Camargo FAO, Alho CS (2020) Evaluation of two 13-loci STR multiplex system regarding identification and origin discrimination of Brazilian Cannabis sativa samples. Int J Legal Med. https://doi.org/10.1007/s00414-020-02338-5
Sampson PB (2020) Phytocannabinoid pharmacology: medicinal properties of Cannabis sativa constituents aside from the “Big Two.” J Nat Prod 84:142–160. https://doi.org/10.1021/ACS.JNATPROD.0C00965
Sarma ND, Waye A, Elsohly MA, Brown PN, Elzinga S, Johnson HE, Marles RJ, Melanson JE, Russo E, Deyton L, Hudalla C, Vrdoljak JA, Wurzer JH, Khan IA, Kim N-C, Giancaspro GI (2020) Cannabis inflorescence for medical purposes: USP considerations for quality attributes. J Nat Prod 83:1334–1351. https://doi.org/10.1021/acs.jnatprod.9b01200
Sheriff T, Lin MJ, Dubin D, Khorasani H (2019) The potential role of cannabinoids in dermatology. J Dermatolog Treat 31:839–845. https://doi.org/10.1080/09546634.2019.1675854
Ternelli M, Brighenti V, Anceschi L, Poto M, Bertelli D, Licata M, Pellati F (2020) Innovative methods for the preparation of medical Cannabis oils with a high content of both cannabinoids and terpenes. J Pharm Biomed Anal 186:113296. https://doi.org/10.1016/j.jpba.2020.113296
Valverde L, Lischka C, Scheiper S, Nedele J, Challis R, Pancorbo MM, Pfeiffer H, Köhnemann S (2014) Characterization of 15 STR cannabis loci: nomenclature proposal and SNPSTR haplotypes. Forensic Sci Int Genet 9:61–65. https://doi.org/10.1016/j.fsigen.2013.11.001
Wagner H, Bladt S (1996) Plant drug analysis: a thin layer chromatography atlas. Springer. Second ed
Wang M, Wang YH, Avula B, Radwan MM, Wanas AS, van Antwerp J, Parcher JF, ElSohly MA, Khan IA (2016) Decarboxylation study of acidic cannabinoids: a novel approach using ultra-high-performance supercritical fluid chromatography/photodiode array-mass spectrometry. Cannabis Cannabinoid Res 1:262–271. https://doi.org/10.1089/can.2016.0020
Zhao Z, Yang J, Zhao H, Fang X, Li H (2012) Cannabinoid receptor 2 is upregulated in melanoma. J Cancer Res Ther 8:549–554. https://doi.org/10.4103/0973-1482.106534
Acknowledgements
Analyses of DNA extraction, amplification, and fragment were performed in the Human and Molecular Genetics Laboratory of Pontifícia Universidade Católica do Rio Grande do Sul by Lucas de O. P. Ribeiro and Clarice Sampaio Alho.
Funding
Financial support was provided by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), and Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC), Brazil.
Author information
Authors and Affiliations
Contributions
PRM, FRMS, and PAA: development/execution of methodology for Cannabis extraction; FRMS: HPLC analysis; RS: development and verification, of the overall replication/reproducibility of results by HPLC analysis; MEM, FKR, and PEF: evaluation/execution of in vitro tests; ABM: conceptualization regarding the use of seized Cannabis as a source of raw material for extract preparation; RAM-de-Á: reagent supply, laboratory materials, instrumentation, and other analytical tools for in vitro analysis; JWB: manuscript preparation, critical review, commentary, and revision; PEF and FKR: application of statistical, mathematical, computational, or other formal techniques to analyze or synthesize study data; FKR and PAA: conceptualization and evolution of overarching research goals and aims; PAA: management and coordination of the research project.
Corresponding author
Ethics declarations
Ethics Approval
All studies in this manuscript were in accordance with the Institutional Review Board and Institutional Animal Care and Use Committee procedures. Experiments reported in this study were approved by the medical ethics committee of UNESC (Criciúma, Brazil), protocol number CAAE 14560419.9.0000.0119.
Conflict of Interest
The authors declare no competing interests.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Milanez, P.R., da Silva, F.M.R., Scussel, R. et al. Cannabis Extracts and Their Cytotoxic Effects on Human Erythrocytes, Fibroblasts, and Murine Melanoma. Rev. Bras. Farmacogn. 31, 750–761 (2021). https://doi.org/10.1007/s43450-021-00200-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43450-021-00200-2